Cardlytics, Inc. — Director's Dealing 2018

Feb 9, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2018-02-08

Reporting Person: Klinck John L. Jr. (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series G Redeemable Convertible Preferred Stock	$		Common Stock (5801)		Direct
Stock Option (Right to Buy)	$20.00	2026-11-17	Common Stock (25000)		Direct

Footnotes

F1: Each share of Series G Redeemable Convertible Preferred Stock is convertible into the Issuer's Common Stock on a one-for-one basis, has no expiration date and will convert upon the closing of the Issuer's initial public offering.

F2: This option became exercisable in twenty-four (24) equal monthly installments commencing on November 17, 2016, provided the Reporting Person continuously provides service to the Issuer through each vesting period.